Pharmaceutical Benefits Scheme restrictions on anti-epileptic drug prescribing promote unsafe and outdated practice

Christian A. Gericke, Terence J. O'Brien

Research output: Contribution to journalArticleOtherpeer-review

Original languageEnglish
Pages (from-to)55-57.e1
Number of pages4
JournalMedical Journal of Australia
Volume211
Issue number2
DOIs
Publication statusPublished - 1 Jul 2019

Keywords

  • Anticonvulsants
  • Epilepsy
  • Health policy
  • Neuropharmacology
  • Patient safety
  • Pharmaceutical Benefits Advisory Committee

Cite this